Earnings improved 1.8% year over year on 6.6% higher revenues. Of the total index members, 85.7% beat on earnings and 57.1% reported a revenue beat.Overall, fourth-quarter 2024 earnings of the Medical sector are expected to improve 12.5% on 8.6% revenue growth. This compares with fourth-quarter 2023 earnings improvement of 11.3% and revenue growth of 11.6%.Major industry players like Boston Scientific, Hologic, BioTechne, STERIS and Align Technology are set to report results tomorrow.Factors Likely to Influence MedTech Stocks' Q4 ResultsReplicating the broader market trend, MedTech or the Zacks-defined Medical Products companies are expected to report collective sales growth for the fourth quarter. Through the months of 2024, the industry showed a gradual increase in the rate of patient visits in hospitals. This high rate of hospitalization led to growing demand for a broad array of medical devices.